focus -WSS

focus

author：hotspot 2025-08-25 08:46:39 - browse：7

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Commercial surrogacy can be ethical, despite pope’s claims

WSS

Does Medicare's free annual wellness visit do any good?

What we need to know about Arena Bioworks

Special counsel alerts court to Trump’s social media post

Pharma needs to include young adults in clinical research

Cognito secures funding to test medical device for Alzheimer's

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

focus

focus

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

The real point of Kenneth Smith’s execution by nitrogen gas

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA drug safety: Singulair case shows systemic surveillance flaws

Medical leaders decry Supreme Court decision on affirmative action

Rock icon Freddie Mercury pre

The cancer drug shortage isn’t new — and neither are the solutions

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Tori Bowie and the unacceptable rates of Black maternal death

Time to name cancers by genetics, not organ of origin, expert says

knowledge

The real point of Kenneth Smith’s execution by nitrogen gas

Cybersecurity threat forces Lurie Children's to take systems offline

Calls for Trump's election interference trial to be televised part of long debate

California Joshua trees severely burned in massive wildfire

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

hotspot

hotspot

knowledge

focus